Guided Therapeutics, Inc. (GTHP)
OTCMKTS: GTHP · Delayed Price · USD
0.0952
-0.0048 (-4.79%)
Apr 26, 2024, 11:26 AM EDT - Market open

Guided Therapeutics Market Cap

Guided Therapeutics has a market cap or net worth of $5.29 million as of April 26, 2024. Its market cap has decreased by -56.72% in one year.

Market Cap
5.29M
Enterprise Value
7.03M
1-Year Change
-56.72%
Ranking
n/a
Category
Stock Price
$0.10

Market Cap Chart

Since April 29, 2019, Guided Therapeutics's market cap has increased from $525.44K to $5.29M, an increase of 907.72%. That is a compound annual growth rate of 58.85%.

History

DateMarket Cap% Change
Apr 24, 20245.41M-7.41%
Apr 23, 20245.84M18.68%
Apr 22, 20244.92M-8.54%
Apr 18, 20245.38M9.34%
Apr 17, 20244.92M-0.11%
Apr 16, 20244.93M-5.10%
Apr 15, 20245.19M4.80%
Apr 12, 20244.96M-16.73%
Apr 11, 20245.95M0.92%
Apr 10, 20245.90M-5.22%
Apr 8, 20246.22M3.60%
Apr 5, 20246.01M-9.05%
Apr 4, 20246.60M-1.57%
Apr 2, 20246.71M3.81%
Apr 1, 20246.46M3.42%
Mar 28, 20246.25M-0.86%
Mar 27, 20246.30M-4.53%
Mar 25, 20246.60M3.46%
Mar 22, 20246.38M-1.40%
Mar 21, 20246.47M7.47%
Mar 20, 20246.02M-6.40%
Mar 19, 20246.43M-3.85%
Mar 18, 20246.69M1.56%
Mar 15, 20246.59M-
Mar 14, 20246.59M-3.03%
View and export this data all the way back to 2019. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly 696.15B
Novo Nordisk 573.09B
UnitedHealth Group 449.26B
Johnson & Johnson 357.92B
Merck & Co. 321.65B
AbbVie 297.12B
AstraZeneca 220.71B
Thermo Fisher 220.40B
Market Cap Rankings